// App-Quantinova.ai

P577 : Drug Induced Liver Injury (DILI) secondary to biologic therapy in IBD: ECCO- CONFER Series

Researchers

Presenter

  • J Lisle

Principal Investigators

  • S Myers

  • D Pugliese

  • T Raine

  • A C de Vries

  • K Katsanos

  • R Filip

  • K Karmiris

  • S Sebastian

Medical Centers

  • IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK

  • Allergy Unit, Presidio Columbus‐ Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • School of Health Sciences and University Hospital of Ioannina, Gastroenterology, Ioannina, Greece

  • IBD Unit, Rzeszow University, Rzeszow, Poland

  • Venizeleio General Hospital, Crete, Greece

  • Hull York Medical School, University of Hull and York, Hull, UK

Locations

  • United Kingdom

  • Italy

  • Netherlands

  • Greece

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Gastroenterology (GU)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved